BIOMAT Database Logo BIOMAT Database Logo

Successful treatment of metastatic glucagonoma with dacarbazine. 1984

T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura

UI MeSH Term Description Entries
D007516 Adenoma, Islet Cell A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM. Islet Cell Tumor,Islet of Langerhans Tumor,Nesidioblastoma,Pancreatic Islet Cell Tumors,Island Cell Tumor,Adenomas, Islet Cell,Island Cell Tumors,Islet Cell Adenoma,Islet Cell Adenomas,Islet Cell Tumors,Langerhans Tumor Islet,Nesidioblastomas,Tumor Islet, Langerhans,Tumor, Island Cell,Tumor, Islet Cell,Tumors, Island Cell,Tumors, Islet Cell
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D005935 Glucagonoma An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA. Adenoma, alpha-Cell,alpha-Cell Tumor,Glucagonoma Syndrome,Adenoma, alpha Cell,Adenomas, alpha-Cell,Glucagonoma Syndromes,Glucagonomas,Syndrome, Glucagonoma,Syndromes, Glucagonoma,Tumor, alpha-Cell,Tumors, alpha-Cell,alpha Cell Tumor,alpha-Cell Adenoma,alpha-Cell Adenomas,alpha-Cell Tumors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
February 1987, Journal of the American Academy of Dermatology,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Glucagonoma and dacarbazine.
December 1982, Annals of internal medicine,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
[Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
January 1988, Annales de dermatologie et de venereologie,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
[Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma].
January 2000, Gastroenterologie clinique et biologique,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
[Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
July 1996, Zeitschrift fur Gastroenterologie,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Metastatic glucagonoma: treatment with liver transplantation.
February 2006, Journal of the American Academy of Dermatology,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
[Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency].
January 2010, Gastroenterologie clinique et biologique,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
October 2010, Veterinary dermatology,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Metastatic glucagonoma.
April 2009, The Eurasian journal of medicine,
T Kurose, and Y Seino, and H Ishida, and J Fujita, and T Taminato, and M Matsukura, and H Imura
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
August 1992, The New England journal of medicine,
Copied contents to your clipboard!